doi:10.19982/j.issn.1000-6621.20230230

Abstract

CLC Number:

Figures/Tables 4

References 19

[1]	García CA, Sangiovanni S, Zúñiga-Restrepo V, et al. Tracheobronchopathia Osteochondroplastica-Clinical, Radiological, and Endoscopic Correlation: Case Series and Literature Review. J Investig Med High Impact Case Rep, 2020, 8:2324709620921609. doi:10.1177/2324709620921609.
[2]	Grünling S, Rosenhagen K, Ullrich W. Osteochondroplastic tracheobronchopathy. Anasthesiol Intensivmed Notfallmed Schmerzther, 2001, 36(2):110-114. doi:10.1055/s-2001-11053.
[3]	Silveira MGM, Castellano MVCO, Fuzi CE, et al. Tracheobronchopathia osteochondroplastica. J Bras Pneumol, 2017, 43(2):151-153. doi:10.1590/S1806-37562016000000143. pmid: 28538784
[4]	Wilks S. Ossific deposits on the larynx, trachea and bronchi. Trans Pathol Soc Lond, 1857, 8: 88.
[5]	Braun H, Dhom G. Verknö cherung des Tracheo-Bronchialskelets mit tödlichem Ausgang [Fatal tracheobronchial ossification]. Z Klin Med, 1954, 151(4):355-366. pmid: 13188195
[6]	Cheng E, Thorpe E. A Unique Surgical Technique for Tracheostomy in Heterotopic Ossification: A Case Report. Ann Otol Rhinol Laryngol, 2016, 125(11):943-946. doi:10.1177/0003489416665193.
[7]	李时悦, 欧阳能太, 钟南山. 骨化性气管支气管病. 中华结核和呼吸杂志, 2001, 24(7):414-416. doi:10.3760/j:issn:1001-0939.2001.07.011.
[8]	Ulasli SS, Kupeli E. Tracheobronchopathia osteochondroplastica: a review of the literature. Clin Respir J, 2015, 9(4):386-391. doi:10.1111/crj.12166. pmid: 24865333
[9]	Zhu Y, Wu N, Huang HD, et al. Clinical study of tracheobronchopathia osteochondroplastica: findings from a large Chinese cohort. PLoS One, 2014, 9(7):e102068. doi:10.1371/journal.pone.0102068.
[10]	Meyer CN, Døssing M, Broholm H. Tracheobronchopathia osteochondroplastica. Respir Med, 1997, 91(8):499-502. doi:10.1016/s0954-6111(97)90117-7.
[11]	Berend N, Harrison AC, Hartnett BJ, et al. Tracheobronchopathia osteochondroplastica. Aust N Z J Med, 1979, 9(2):188-192. doi:10.1111/j.1445-5994.1979.tb04327.x. pmid: 287464
[12]	胡智敏, 吴鸣镝, 向嵘, 等. 骨化性气管支气管病误诊三例分析. 中国防痨杂志, 2016, 38(9):777-781. doi:10.3969/j.issn.1000-6621.2016.09.017.
[13]	Bottles K, Nyberg DA, Clark M, et al. CT diagnosis of tracheobronchopathia osteochondroplastica. J Comput Assist Tomogr, 1983, 7(2):324-327. doi:10.1097/00004728-198304000-00024. pmid: 6833569
[14]	Hong Y, Shan S, Gu Y, et al. Malfunction of airway basal stem cells plays a crucial role in pathophysiology of tracheobronchopathia osteoplastica. Nat Commun, 2022, 13(1):1309. doi:10.1038/s41467-022-28903-7. pmid: 35288560
[15]	朱莹, 邬盛昌, 胥武剑, 等. 骨化性气管支气管病临床分析. 中国呼吸与危重监护杂志, 2012, 11(6):592-595.
[16]	Li D, Jin F, Nan Y, et al. Multi-nodule of large airway: tracheobronchopathia osteochondroplastica. Ann Palliat Med, 2021, 10(2):1115-1121. doi:10.21037/apm-20-316. pmid: 33183038
[17]	Nienhuis DM, Prakash UB, Edell ES. Tracheobronchopathia osteochondroplastica. Ann Otol Rhinol Laryngol, 1990, 99(9 Pt 1):689-694. doi:10.1177/000348949009900903.
[18]	Jabbardarjani HR, Radpey B, Kharabian S, et al. Tracheobronchopathia osteochondroplastica: presentation of ten cases and review of the literature. Lung, 2008, 186(5):293-297. doi:10.1007/s00408-008-9088-4. pmid: 18463923
[19]	Lim SY, Abu Samah MF, Pereirasamy L, et al. Tracheobronchopathia osteochondroplastica-stalactite of airways. Respirol Case Rep, 2021, 9(7):e00790. doi:10.1002/rcr2.790.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 19

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
[2]	Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407.
[3]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[4]	Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
[5]	Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431.
[6]	An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
[7]	Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443.
[8]	Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
[9]	Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
[10]	Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470.
[11]	Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476.
[12]	Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
[13]	Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497.
[14]	Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504.
[15]	Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512.